LYRM03
Product Specifications
CAS Number
1820750-36-4
Target
Others
Related Pathways
Others
Bioactivity
LYRM03 is an aminopeptidase inhibitor. LYRM03 is also an ubenimex derivative. LYRM03 attenuates LPS-induced acute lung injury in mice by suppressing the TLR4 signaling pathway. LYRM03 effectively attenuates LPS-induced ALI by inhibiting the expression of pro-inflammatory mediators and Myd88-dependent TLR4 signaling pathways in alveolar macrophages. LYRM03 may serve as a potential treatment for sepsis-mediated lung injuries.
Smiles
[C@H](C(N[C@@H]([C@H](CC)C)C(O)=O)=O)(NC([C@H]([C@@H](CC1=CC=CC=C1)N)O)=O)C(C)C
Molecular Formula
C21H33N3O5
Molecular Weight
407.5
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNCB0731-100 1x 100 µL
AMACR / p504S (Rabbit PAb), Biotin conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
